Reproductive carrier screening: GP guidance on risk and management – Part 1

   Rated 5 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

1 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0.5 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
1 hours

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0.5 hours

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 hours

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

In this episode:

  • Reproductive carrier screening (RCS) should be proactively integrated into preconception care
  • The 3-gene, Medicare-funded panel screens for cystic fibrosis (CF), spinal muscular atrophy (SMA) and fragile X syndrome (FXS)
  • A low-risk carrier screening result is reassuring, but not absolute
  • Partner testing is essential when a patient is identified as a carrier
  • Fragile X results may have implications for the patient’s own health
  • Genetic counselling and clear documentation are critical components of care
  • Healthcare professionals play a critical role in supporting patients to understand and manage RCS and its implications

 

Experts: A/Prof Marina Berbic, Genetic Pathologist
Wendy Bruce, Executive Director of Fragile X Association of Australia

Host: Dr Sara Whitburn, General Partitioner

Total time: 58 mins

 

Recommended resources:

 

Last Updated: 20 Jun, 2025

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Belinda Welsh

Dr Belinda Welsh

Rosacea – Smarter Diagnosis and State-of-the-Art Care

A/Prof Ralph Audehm & Prof Genie Pedagogos

A/Prof Ralph Audehm & Prof Genie Pedagogos

The Role of SGLT2 Inhibitors in Preventing Dialysis

Prof Jason Ong

Prof Jason Ong

Syphilis is on the Rise – What GPs Can do to Turn it Around

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

COPD Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

A/Prof Marina Berbic

expert

A/Prof Marina Berbic

Genetic Pathologist; Deputy Director - Genetics, Douglass Hanly Moir

Wendy Bruce

expert

Wendy Bruce

Executive Director; Fragile X Association of Australia

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.